Management of Pulmonary Hypertension Associated with Left Heart Disease

被引：4

作者：

Franco, Veronica ^{[1
]}

机构：

[1] Ohio State Univ, Div Cardiovasc Dis, Pulm Hypertens Program, Adv Heart Failure LVAD & Transplantat Program, DHLRI Suite 200,473 West 12th Ave, Columbus, OH 43210 USA

来源：

HEART FAILURE CLINICS | 2018年 / 14卷 / 04期

关键词：

Hypertension; Heart failure; Ejection fraction; Right ventricular; Pulmonary hypertension; Pulmonary arterial hypertension; GUANYLATE-CYCLASE STIMULATOR; PRESERVED EJECTION FRACTION; VENTRICULAR ASSIST DEVICE; DOUBLE-BLIND; INTERNATIONAL SOCIETY; CLINICAL-OUTCOMES; PRESSURE-GRADIENT; LISTING CRITERIA; FLUID CHALLENGE; FAILURE;

D O I：

10.1016/j.hfc.2018.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary hypertension (PH) due to left heart disease, or WHO group 2 PH, is the most frequent cause of PH. It affects approximately 50% to 60% of patients with heart failure with preserved ejection fraction as well as 60% of those with heart failure with reduced ejection fraction and contributes significantly to disease progression and unfavorable outcomes. The diagnosis of PH is associated with poor prognosis and significant morbidity and mortality.

引用

页码：545 / +

页数：8

共 50 条

[41] Pathogenesis of pulmonary hypertension caused by left heart disease
Xiao, Mingzhu
Lai, Disheng
Yu, Yumin
Wu, Qingqing
Zhang, Caojin
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[42] Physiological Techniques and Pulmonary Hypertension - Left Heart Disease
Agarwal, Manyoo
Waxman, Aaron B.
PROGRESS IN CARDIOVASCULAR DISEASES, 2016, 59 (01) : 30 - 41
[43] Pulmonary Hypertension Associated With Left Heart Disease: Characteristics, Emerging Concepts, and Treatment Strategies
Haddad, Francois
Kudelko, Kristina
Mercier, Olaf
Vrtovec, Bojan
Zamanian, Roham T.
Perez, Vinicio de Jesus
PROGRESS IN CARDIOVASCULAR DISEASES, 2011, 54 (02) : 154 - 167
[44] Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011
Rosenkranz, Stephan
Bonderman, Diana
Buerke, Michael
Felgendreher, Ralf
ten Freyhaus, Henrik
Gruenig, Ekkehard
de Haan, Fokko
Hammerstingl, Christoph
Harreuter, Alexander
Hohenforst-Schmidt, Wolfgang
Kindermann, Ingrid
Kindermann, Michael
Kleber, Franz X.
Kuckeland, Matthias
Kuebler, Wolfgang M.
Mertens, Dirk
Mitrovic, Veselin
Opitz, Christian
Schmeisser, Alexander
Schulz, Uwe
Speich, Rudolf
Zeh, Wolfgang
Weil, Joachim
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 154 : S34 - S44
[45] Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension
Aleevskaya, A. M.
Vyborov, O. N.
Gramovich, V. V.
Martynyuk, T., V
TERAPEVTICHESKII ARKHIV, 2020, 92 (09) : 54 - 62
[46] Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management
Ltaief, Zied
Yerly, Patrick
Liaudet, Lucas
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
[47] Current Treatment Strategies in Pulmonary Hypertension Associated with Left Heart Disease
Selby V.N.
De Marco T.
Current Transplantation Reports, 2015, 2 (4) : 345 - 354
[48] Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation
Koulova, Anna
Gass, Alan L.
Patibandla, Saikrishna
Gupta, Chhaya Aggarwal
Aronow, Wilbert S.
Lanier, Gregg M.
JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2640 - 2649
[49] Pulmonary hypertension in heart failure
Duran, Antonio
Mandras, Stacy
CURRENT OPINION IN CARDIOLOGY, 2021, 36 (02) : 205 - 210
[50] Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
Lteif, Christelle
Ataya, Ali
Duarte, Julio D.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (11):

← 1 2 3 4 5 →